![Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial - ScienceDirect Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213260019304175-gr1.gif)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial - ScienceDirect
Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial | PLOS ONE
![Prognosis of acute respiratory distress syndrome in neutropenic cancer patients | European Respiratory Society Prognosis of acute respiratory distress syndrome in neutropenic cancer patients | European Respiratory Society](https://erj.ersjournals.com/content/erj/40/1/169/F1.large.jpg)
Prognosis of acute respiratory distress syndrome in neutropenic cancer patients | European Respiratory Society
![Clinical trials in acute respiratory distress syndrome: challenges and opportunities - The Lancet Respiratory Medicine Clinical trials in acute respiratory distress syndrome: challenges and opportunities - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/a0aa07e5-9273-456a-9b23-246a7959b2cf/gr1_lrg.jpg)
Clinical trials in acute respiratory distress syndrome: challenges and opportunities - The Lancet Respiratory Medicine
![Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure | Scientific Reports Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-88231-6/MediaObjects/41598_2021_88231_Fig1_HTML.png)
Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure | Scientific Reports
![Diagnostics | Free Full-Text | Diagnosis and Management of Acute Respiratory Distress Syndrome in a Time of COVID-19 Diagnostics | Free Full-Text | Diagnosis and Management of Acute Respiratory Distress Syndrome in a Time of COVID-19](https://pub.mdpi-res.com/diagnostics/diagnostics-10-01053/article_deploy/html/images/diagnostics-10-01053-g001.png?1607300831)
Diagnostics | Free Full-Text | Diagnosis and Management of Acute Respiratory Distress Syndrome in a Time of COVID-19
![Frontiers | Comparison of COVID-19 Induced Respiratory Failure and Typical ARDS: Similarities and Differences Frontiers | Comparison of COVID-19 Induced Respiratory Failure and Typical ARDS: Similarities and Differences](https://www.frontiersin.org/files/MyHome%20Article%20Library/829771/829771_Thumb_400.jpg)
Frontiers | Comparison of COVID-19 Induced Respiratory Failure and Typical ARDS: Similarities and Differences
![Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management - The Lancet Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management - The Lancet](https://www.thelancet.com/cms/attachment/ecb20dfe-c1d9-4722-96b3-f47303396095/gr1_lrg.jpg)
Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management - The Lancet
![Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial - The Lancet Respiratory Medicine Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/555feb8c-fd20-4e05-9612-fd49d29b8273/gr1.gif)
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial - The Lancet Respiratory Medicine
![Treatment for severe acute respiratory distress syndrome from COVID-19 - The Lancet Respiratory Medicine Treatment for severe acute respiratory distress syndrome from COVID-19 - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/2b7e5bc9-c30b-4853-9e48-11f00bffe02e/gr1.jpg)
Treatment for severe acute respiratory distress syndrome from COVID-19 - The Lancet Respiratory Medicine
![Liver–lung interactions in acute respiratory distress syndrome | Intensive Care Medicine Experimental | Full Text Liver–lung interactions in acute respiratory distress syndrome | Intensive Care Medicine Experimental | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40635-020-00337-9/MediaObjects/40635_2020_337_Fig1_HTML.png)
Liver–lung interactions in acute respiratory distress syndrome | Intensive Care Medicine Experimental | Full Text
![Effectiveness of prone position in acute respiratory distress syndrome and moderating factors of obesity class and treatment durations for COVID-19 patients: A meta-analysis - ScienceDirect Effectiveness of prone position in acute respiratory distress syndrome and moderating factors of obesity class and treatment durations for COVID-19 patients: A meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S096433972200060X-gr1.jpg)
Effectiveness of prone position in acute respiratory distress syndrome and moderating factors of obesity class and treatment durations for COVID-19 patients: A meta-analysis - ScienceDirect
![Membranes | Free Full-Text | Cumulative Fluid Balance during Extracorporeal Membrane Oxygenation and Mortality in Patients with Acute Respiratory Distress Syndrome Membranes | Free Full-Text | Cumulative Fluid Balance during Extracorporeal Membrane Oxygenation and Mortality in Patients with Acute Respiratory Distress Syndrome](https://www.mdpi.com/membranes/membranes-11-00567/article_deploy/html/images/membranes-11-00567-g001.png)